Michael Lincoff, MD, Cleveland Clinic, lead author of SELECT [1] changed how we think about these medications." Undereating is a real problem on GLP-1 treatment
This dual action not only enhances the effects seen with GLP-1 receptor agonists but also adds the insulinotropic and glucagonostatic effects of GIP, which further aids in glucose control and weight loss
Os locais recomendados so o abdmen, a coxa ou a parte de trs do brao, alternando o ponto a cada dose para evitar irritaes
2.4 Outcomes assessed The primary outcome was the incidence of any gastrointestinal (GI) cancer, including pancreatic, colorectal, gastric, and liver cancers
But the mechanisms have shifted
Understanding these benefits helps clarify the peptides potential applications and limitations